Trials and fast changing technologies: the case for tracker studies

被引：76

作者：

Lilford, RJ

Braunholtz, DA ^{[1
]}

Greenhalgh, R

Edwards, SJL

机构：

[1] Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England

[2] Charing Cross Hosp, Univ London Imperial Coll Sci Technol & Med, London W6 8RF, England

来源：

BRITISH MEDICAL JOURNAL | 2000年 / 320卷 / 7226期

关键词：

D O I：

10.1136/bmj.320.7226.43

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：43 / 46

页数：4

共 33 条

[1]

Banta H D, 1978, J Community Health, V3, P245, DOI 10.1007/BF01349387

[2]

Berry D A, 1995, Cancer Treat Res, V75, P125

[3] SAMPLE SIZES FOR PHASE-II CLINICAL-TRIALS DERIVED FROM BAYESIAN DECISION-THEORY [J].

BRUNIER, HC ;

WHITEHEAD, J .

STATISTICS IN MEDICINE, 1994, 13 (23-24) :2493-2502

[4] The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials [J].

Bucher, HC ;

Guyatt, GH ;

Griffith, LE ;

Walter, SD .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (06) :683-691

[5]

Carlin BP, 1996, STAT MED, V15, P1093, DOI 10.1002/(SICI)1097-0258(19960615)15:11<1093::AID-SIM231>3.0.CO

[6]

2-0

[7]

CHALMERS TC, 1968, LANCET, V1, P858

[8]

EDWARDS SJL, 1999, 1998215 NHS HTA

[9]

FEINSTEIN AR, 1983, ANN INTERN MED, V99, P544, DOI 10.7326/0003-4819-99-4-544

[10] THE WHAT, WHY AND HOW OF BAYESIAN CLINICAL-TRIALS MONITORING [J].

FREEDMAN, LS ;

SPIEGELHALTER, DJ ;

PARMAR, MKB .

STATISTICS IN MEDICINE, 1994, 13 (13-14) :1371-1383

← 1 2 3 4 →